Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

Testing of the MGMT promoter methylation status in glioblastoma is relevant for clinical decision making and research applications. Two recent and independent phase III therapy trials confirmed a prognostic and predictive value of the MGMT promoter methylation status in elderly glioblastoma patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Preusser, Matthias, Berghoff, Anna S., Manzl, Claudia, Filipits, Martin, Weinhäusel, Andreas, Pulverer, Walter, Dieckmann, Karin, Widhalm, Georg, Wöhrer, Adelheid, Knosp, Engelbert, Marosi, Christine, Hainfellner, Johannes A.
Formato: Artigo
Idioma:Inglês
Publicado em: Dustri-Verlag Dr. Karl Feistle 2014
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891253/
https://ncbi.nlm.nih.gov/pubmed/24359605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300730
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados